Veltiro 500 Mg Injection

₹ 6,450/Vial

BrandVeltiro 500 Mg Injection
Packaging TypeBottle
Packaging Size50 ml
Country of OriginMade in India
Warning and PrecautionRheumatoid Arthritis
ManufacturerZydus
Packagingvial
Dosage Form500 mg
AvailabilityIn Stock
Introduction to Veltiro 500mg Injection

Veltiro 500mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin's lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the body cells of its own joints)  in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.  

Veltiro 500mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.  

Common side effects of Veltiro 500mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.

Uses of Veltiro 500mg Injection
  • Non-hodgkin's lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • Rheumatoid Arthritis
  • Granulomatosis with polyangiitis or microscopic polyangiitis
  • Pemphigus vulgaris

Therapeutic Effects of Veltiro 500mg Injection

Veltiro 500mg injection  is a monoclonal antibody that targets the antigen CD20 expressed on the cell surface of B-lymphocytes (a type of white blood cells). When this medicine binds to the B-cell, it induces cell death in NHL and CLL. The binding action blocks cell activation and growth and cause anticancer effects. It inhibits rheumatoid factor production, antigen presentation, T-cell activation, and proinflammatory cytokine production in rheumatoid arthritis. 

Interaction of Veltiro 500mg Injection with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. In particular, tell your doctor if you are taking medicines for blood pressure or other heart conditions. Certain medications may interact with Veltiro 500mg injection and reduce its effectiveness by causing undesirable side effects. 

More Information about Veltiro 500mg Injection
  • Store Veltiro 500mg injection  in the refrigerator (2°C to 8°C)

Exports To: United States Of America | Ethiopia | Iraq | Tanzania | Bangladesh

Find products similar to Veltiro 500 Mg Injection

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromMumbai
ShippingAs per delivery location

About the Company

GST Registration Date
Aug 2024
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Aug 2024
GST
27**********1ZS
Import Export Code (IEC)
*******70G
Exports to
United States Of America | Ethiopia | Iraq | Tanzania | Bangladesh

Established in 2024, Salunkhe and Sons Pharmaceuticals Private Limited is a trusted and emerging organization engaged as a leading wholesaler, trader, and exporter of a comprehensive range of pharmaceutical products, including pharmaceutical injections, tablets, and anti-cancer medicines.

All our products are sourced from reputed manufacturers who adhere strictly to industry standards and regulatory norms, ensuring superior quality and reliability. Our medicines are formulated using high-grade ingredients under the supervision of experienced professionals, with stringent quality checks conducted at every stage to ensure consistency, safety, and efficacy.

We emphasize that all pharmaceutical products should be used strictly under the guidance of qualified medical practitioners. To preserve their effectiveness and ensure optimal quality, our products are packaged using hygienic, secure, and air-tight materials.

With a commitment to quality, integrity, and customer satisfaction, we strive to build long-term relationships with our clients while delivering dependable healthcare solutions.


Under the valuable guidance of our mentor Mr. Rishikesh Salunkhe, we have attained a formidable position in the highly competitive market. His vibrant leadership, constant motivation and in-depth knowledge of the industry have enabled us to stand apart from our counterpart and gain faith of numerous clients across the region.